(EMAILWIRE.COM, June 11, 2021 ) The research study involved four major activities in estimating the current size of the European Mammography Workstations Market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Expected Revenue Surge: The European Mammography Workstations Market is estimated to grow at a CAGR of 5.5% to reach $14 million.

Recent Developments;

- In February 2019, Fujifilm (Japan) launched ASPIRE Bellus II.

- In January 2018, Agfa-Gevaert NV (Belgium) signed a contract with the West Suffolk NHS Foundation Trust (UK) in order to implement enterprise imaging for radiology platform.

- In May 2017, Siemens AG (Germany) and Fraunhofer MEVIS (Germany) entered into a partnership for developing artificial intelligence software systems to facilitate diagnosis and therapy decisions in order to support physicians to define the best possible treatment approach.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=101392240

Market Segmentation in Detailed:

Based on Modality,

Segmented into mammography (X-ray) workstations and multimodality mammography workstations. In 2018, the multimodality mammography workstations segment accounted for the larger share of the European mammography workstations market. This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.

Based on Applications;

The European mammography workstations industry is segmented into diagnostic screening, advanced imaging, and clinical review. The diagnostic screening segment accounted for the largest share of the market in 2018, and this trend is expected to continue during the forecast period. This can be attributed to the ongoing market transition from 2D to 3D clinical diagnostics; the market shift from single-modality workstations to multimodality diagnostic imaging; greater integration of key Diagnostic Imaging modalities with PACS, Artificial Intelligence (AI), and cloud-based platforms across mature countries; and the large end-user base for mammography in Europe coupled with their ongoing integration with imaging workstations across key countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101392240

Geographically; Germany accounted for the largest share of the European mammography workstations market in 2018. The large share of Germany is primarily attributed to the better reimbursement scenario in the country as compared to other European countries, wider acceptance of multimodality mammography workstations among major end users (such as hospitals, surgical clinics, and breast care centers), and the rising patient demand for improved cancer screening.

General Electric (US), Siemens (Germany), FUJIFILM Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy) are the major players in the European mammography workstations market.